The Intravitreal Autologous Platelet Concentrate Injection as an Adjunct of Vitrectomy for the Treatment of Refractory Macular Holes

Large Size Macular Hole (Diameter > 600 Microns) or Clinical Trial

Status Recruiting

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of intravitreal autologous platelet concentrate (APC) injection during the surgery for refractory macular holes.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Large Size Macular Hole (Diameter > 600 Microns) or
• Macular Hole With High Myopia (Spherical Equivalent = -6.0 Diopters) or,
• or Chronic Macular Hole (Symptom Duration > 6 Months)
• Recurred or Failed Macular Hole From Previous Surgery
• Retinal Perforations

• NCT number: NCT02081170
• Study type: Interventional
• Source: Samsung Medical Center
• Contact: Ga Eun Cho, MD
• Phone: +82-3410-3548
• Status: Recruiting
• Phase: N/A
• Start date: December 2013